Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent ...

The artemisia annua plant, also known as sweet wormwood, has long provided a key ingredient in treating malaria The World Health Organization (WHO) is to test a malaria drug on Covid patients ...

Artemisia annua, known commonly as sweet wormwood, sweet Annie, and qinghao, is a shrub native to China long used both ornamentally and for medicinal purposes.

Could Artemisia annua offer hope?. Despite intensive research efforts, there have been no breakthroughs in the development of orally administered small molecule therapeutics.

Still, some aren’t willing to give up on A. annua as a source of COVID-19 treatments. In April, California biotech company Mateon Therapeutics announced in a press release that tests showed ...

Growing Artemisia annua and producing and testing the tablets, Weathers noted, are ideal local business that can provide jobs in impoverished areas and greatly expand access to antimalarial therapy.

Artemisia annua is celebrated for its production of artemisinin, a powerful antimalarial agent. Although its glandular secretory trichomes have been the focus of extensive research, a complete ...

A derivative of the Artemisia annua plant, also known as sweet wormwood, has long been used in the treatment of malaria. Scientists are currently testing the plant’s potential against the novel ...

Artemisinin is a potent antimalarial compound produced naturally in low amounts by the Chinese shrub Artemisia annua, commonly known as sweet wormwood. Researchers in China now report a high ...

ArtemiLife products use Artemisia annua plants grown at two Kentucky farms in Georgetown and Lancaster. Provided by University of Kentucky. This story was originally published on Medical Xpress.